Skip to main content

Table 2 Adjusting for gender, age, targeted and immunotherapy (multivariate analysis)

From: Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma

  (1) (2) (3) (4)
ECP > 16 1.869* (0.893, 3.913) 1.869* (0.893, 3.913) 1.873* (0.895, 3.918) 1.300 (0.578, 2.922)
gender   0.999 (0.482, 2.074) 0.987 (0.475, 2.053) 0.692 (0.311, 1.538)
age    1.006 (0.977, 1.035) 1.008 (0.978, 1.039)
Targeted therapy     0.728 (0.318, 1.663)
Immunotherapy     0.327** (0.130, 0.826)
Observations 56 56 56 56
R2 0.050 0.050 0.053 0.146
Max. Possible R2 0.982 0.982 0.982 0.982
Log Likelihood − 110.967 −110.967 −110.893 −107.992
Wald Test 2.760* (df = 1) 2.760 (df = 2) 2.900 (df = 3) 7.910 (df = 5)
LR Test 2.894* (df = 1) 2.894 (df = 2) 3.044 (df = 3) 8.846 (df = 5)
Score (Logrank) Test 2.841* (df = 1) 2.841 (df = 2) 2.985 (df = 3) 8.503 (df = 5)
  1. Note: *p < 0.1; **p < 0.05